(Q36766691)

16 August 2017

1 reference

title

Eosinophilic esophagitis: an allergist's approach (English)

1 reference

16 August 2017

main subject

eosinophilic esophagitis

1 reference

John M Norvell

1

1 reference

16 August 2017

Daniel Venarske

series ordinal

2

1 reference

16 August 2017

Donna S Hummell

series ordinal

3

1 reference

16 August 2017

publication date

1 March 2007

1 reference

Annals of Allergy, Asthma & Immunology

16 August 2017

published in

1 reference

16 August 2017

volume

98

1 reference

16 August 2017

issue

3

1 reference

16 August 2017

page(s)

207-14; quiz 214-7, 238

1 reference

Esophageal eosinophilia with dysphagia. A distinct clinicopathologic syndrome

16 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960708-9

7 January 2021

Eosinophilic esophagitis attributed to gastroesophageal reflux: improvement with an amino acid-based formula

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960708-9

7 January 2021

Radiographic manifestations of eosinophilic gastroenteritis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960708-9

7 January 2021

The differential diagnosis of eosinophilic esophagitis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960708-9

7 January 2021

Correlation between number of eosinophils and reflux index on same day esophageal biopsy and 24 hour esophageal pH monitoring

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960708-9

7 January 2021

Eosinophilic esophagitis: strictures, impactions, dysphagia

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960708-9

7 January 2021

Severity of esophageal eosinophilia predicts response to conventional gastroesophageal reflux therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960708-9

7 January 2021

Esophageal eosinophilia in children with dysphagia

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960708-9

7 January 2021

Elemental diet is an effective treatment for eosinophilic esophagitis in children and adolescents

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960708-9

7 January 2021

Allergic esophagitis in children: a clinicopathological entity

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960708-9

7 January 2021

Primary eosinophilic esophagitis in children: successful treatment with oral corticosteroids

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960708-9

7 January 2021

Eosinophilic esophagitis in children: immunopathological analysis and response to fluticasone propionate

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960708-9

7 January 2021

The use of skin prick tests and patch tests to identify causative foods in eosinophilic esophagitis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960708-9

7 January 2021

Pathogenesis and clinical features of eosinophilic esophagitis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960708-9

7 January 2021

Eosinophilic esophagitis: red on microscopy, white on endoscopy.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960708-9

7 January 2021

Adherent white plaques: an endoscopic finding in eosinophilic esophagitis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960708-9

7 January 2021

Eosinophil infiltration and degranulation in normal human tissue

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960708-9

7 January 2021

Fundamental signals that regulate eosinophil homing to the gastrointestinal tract

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960708-9

7 January 2021

An etiological role for aeroallergens and eosinophils in experimental esophagitis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960708-9

7 January 2021

Cloning of the human eosinophil chemoattractant, eotaxin. Expression, receptor binding, and functional properties suggest a mechanism for the selective recruitment of eosinophils

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960708-9

7 January 2021

Infiltrating eosinophils and eotaxin: their association with idiopathic eosinophilic esophagitis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960708-9

7 January 2021

Eotaxin-3 and a uniquely conserved gene-expression profile in eosinophilic esophagitis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960708-9

7 January 2021

Idiopathic eosinophilic esophagitis is associated with a TH2-type allergic inflammatory response

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960708-9

7 January 2021

A pathological function for eotaxin and eosinophils in eosinophilic gastrointestinal inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960708-9

7 January 2021

Mechanisms of eosinophil-associated inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960708-9

7 January 2021

Human eosinophil major basic protein is an endogenous allosteric antagonist at the inhibitory muscarinic M2 receptor

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960708-9

7 January 2021

Leukotrienes and other products of the 5-lipoxygenase pathway. Biochemistry and relation to pathobiology in human diseases

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960708-9

7 January 2021

Paediatric eosinophilic oesophagitis: towards early diagnosis and best treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960708-9

7 January 2021

Treatment of eosinophilic esophagitis with specific food elimination diet directed by a combination of skin prick and patch tests.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960708-9

7 January 2021

Pollen and eosinophilic esophagitis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960708-9

7 January 2021

Eosinophilic esophagitis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960708-9

7 January 2021

Eosinophilic esophagitis: Escalating epidemiology?

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960708-9

7 January 2021

Epidemiologic and clinical characteristics of children with newly diagnosed inflammatory bowel disease in wisconsin: a statewide population-based study

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960708-9

7 January 2021

Eosinophilic esophagitis in children: symptoms, histology and pH probe results

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960708-9

7 January 2021

Eosinophil-associated gastrointestinal disorders: a world-wide-web based registry.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960708-9

7 January 2021

Long-term follow-up of symptoms and peripheral eosinophil counts in seven children with eosinophilic esophagitis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960708-9

7 January 2021

Treatment of eosinophilic esophagitis in children

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960708-9

7 January 2021

Clinical and immunopathologic effects of swallowed fluticasone for eosinophilic esophagitis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960708-9

7 January 2021

Treatment of eosinophilic esophagitis with inhaled corticosteroids

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960708-9

7 January 2021

Topical corticosteroid treatment of dysphagia due to eosinophilic esophagitis in adults

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960708-9

7 January 2021

The human pharmacology of fluticasone propionate

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960708-9

7 January 2021

Eosinophilic oesophagitis: a novel treatment using Montelukast

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960708-9

7 January 2021

Anti-interleukin-5 (mepolizumab) therapy for hypereosinophilic syndromes.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960708-9

7 January 2021

10.1016/S1081-1206(10)60708-9

Identifiers

DOI

1 reference

release_ofinpllxlfdrrjmus3w35cxjda

16 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/ofinpllxlfdrrjmus3w35cxjda

24 November 2022

mapped directly with Wikidata item

1 reference